ClinicalTrials.gov
public full text
Public Domain
Moderate Dose Hydroxyurea for Secondary Stroke Prevention in Children With Sickle Cell Disease in Sub-Saharan Africa
The overall goal of the proposed study is to determine the effectiveness of hydroxyurea therapy for secondary stroke prevention and prevention of other neurological events in children with SCA with an acute overt stroke.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Stroke Prevention With Hydroxyurea Enabled Through Research and Education (SPHERE)#969161
- Secondary Prevention of Stroke Through Non-drug Therapeutic Weight Reduction#860620
- SouthErn China REgisTry for Stroke on Traditional Chinese Medicine#1263141
- Problem-solving: A Stroke Caregiver Early Intervention#858472
- Stroke Health and Risk Education (SHARE)#1418497
Record · ID 1429484
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive